RHUPH20/RITUXIMAB: 18 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
18
Total FAERS Reports
3 (16.7%)
Deaths Reported
13
Hospitalizations
18
As Primary/Secondary Suspect
2
Life-Threatening
First Report: 20120427 · Latest Report: 20140425
What Are the Most Common RHUPH20/RITUXIMAB Side Effects?
#1 Most Reported
Injection site erythema
2 reports (11.1%)
#2 Most Reported
Rectal cancer
1 reports (5.6%)
#3 Most Reported
Pyrexia
1 reports (5.6%)
All RHUPH20/RITUXIMAB Side Effects by Frequency
No side effect data available.
Who Reports RHUPH20/RITUXIMAB Side Effects? Age & Gender Data
Average age: 66.4 years. Most reports from: FR. View detailed demographics →
Is RHUPH20/RITUXIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 4 | 1 | 1 |
| 2013 | 7 | 2 | 5 |
| 2014 | 7 | 0 | 7 |
What Is RHUPH20/RITUXIMAB Used For?
| Indication | Reports |
|---|---|
| B-cell lymphoma | 10 |
| Diffuse large b-cell lymphoma | 6 |
Official FDA Label for RHUPH20/RITUXIMAB
Official prescribing information from the FDA-approved drug label.